Three Indian pharmaceutical companies have started developing Nepal with life-saving anti-viral remedies to be used for the treatment of COVID-19 patients. Three companies of the country started the supply of life-saving Remedisvir in Nepal, till now there was no anti-viral available.

Remadecivir drug effective for the treatment of critical patients. (File photo)

Three pharmaceutical companies in India have started supplying life-saving drug Remedisvir to Nepal. Anti viral medicine is used to treat corona patients. This medicine was not available in Nepal till now.

Drug Administration Department Director General Narayan Prasad Thakal said that we have allowed three companies to supply Remedesvir. According to our demands, Mylan, Cipla and Hetro Drugs will supply anti-viral drugs. We will only allow the use of anti-viral supplies supplied by these companies.

Low cost in procuring medicine from India

He said that of these, Mylan has started delivery of anti-viral to Nepal. First of all, we have ordered its 570 vials, which have also been delivered. He said that access to Indian companies is easy. It costs less to get it from there, so we allowed them.

Presently medicine has to be ordered under special arrangement

Remadecivir has proved to be effective for those patients who are placed in Intensive Care Unit (ICU). DG Dhakal said, “A bottle will cost about 7,800 Nepalese rupees when it comes to Nepali market.” The family of patients who are critical in Nepal have to get it from India under special arrangements. It will be easily available to those visiting Nepal. There will be savings in their expenses as well.

India always ahead for help

The Director General of Nepal's Drug Administration Department said that Indian companies always come forward to export drugs and pharmaceuticals to the country. Of the 123 companies that have been allowed to import drugs from other countries, more than half are Indian companies, which operate separately for parent companies with headquarters in Europe or America.

0